XML 37 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 10 - Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2013
Stockholders' Equity Note [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

 

 

LiqTech

International, Inc.

 

Expected term (Years)

 

 

 

4

 

 

Volatility

 

 

 

40.74

 

 

Risk free interest rate

 

 

 

0.67%

 

 

Dividend yield

 

 

 

0%

 

 

Schedule of Share-based Compensation, Activity [Table Text Block]

 

 

 

 

 

 

Options Outstanding

 

 

Options Exercisable

 

 

Range of

Exercise

Prices

 

 

Number

Outstanding

 

 

Weighted

Average

Remaining

Contractual

Life (years)

 

 

Weighted

Average

Exercise

Price

 

 

Number

Exercisable

 

 

Weighted

Average

Exercise

Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$1.50  

 

 

 

452,500

 

 

 

1.40

 

 

$

1.50

 

 

 

452,500

 

 

$

1.50

 

 

 

 

$2.35 

 

 

 

600,000

 

 

 

3.50

 

 

$

2,35

 

 

 

150,000

 

 

$

2,35

 

 

$3.00

 -

$3.60

 

 

 

1,511,630

 

 

 

1.43

 

 

$

3.06

 

 

 

1,440,253

 

 

$

3.04

 

 

 

Total 

 

 

 

 

2,564,130

 

 

 

1.89

 

 

$

2.62

 

 

 

2,042,753

 

 

$

2.65

 

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
   

September 30, 2013

 
   

Shares

   

Weighted

Average

Exercise

Price

   

Average

Remaining

Life

   

Weighted

Average

Intrinsic

Value

 
                                 

Outstanding at beginning of period

    1,964,130     $ 2.70       2.15     $ 0  

Granted

    600,000       2.35       3.50       -  

Exercised

    -       -       -       -  

Forfeited

    -       -       -       -  

Expired

    -       -       -       -  

Outstanding at end of period

    2,564,130     $ 2.62       1.89     $ 700,375  

Vested and expected to vest

    2,564,130     $ 2.62       1.89     $ 700,375  

Exercisable end of period

    2,042,753     $ 2.65       1.63     $ 565,375